Wendy Hague

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. ncbi request reprint Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study
    Wendy Hague
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
    Am Heart J 145:643-51. 2003
  2. ncbi request reprint Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial
    Anthony Keech
    National Health Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
    Diabetes Care 26:2713-21. 2003
  3. ncbi request reprint Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
    R John Simes
    National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia
    Circulation 105:1162-9. 2002
  4. doi request reprint Low-dose aspirin for preventing recurrent venous thromboembolism
    Timothy A Brighton
    Department of Haematology, South Eastern Area Laboratory Services SEALS, Prince of Wales Hospital, Sydney, Australia
    N Engl J Med 367:1979-87. 2012

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study
    Wendy Hague
    NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
    Am Heart J 145:643-51. 2003
    ..The aim of this subgroup analysis was to assess the effects of pravastatin in women...
  2. ncbi request reprint Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial
    Anthony Keech
    National Health Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
    Diabetes Care 26:2713-21. 2003
    ..0 years, on the risk of CHD death or nonfatal myocardial infarction and other cardiovascular outcomes in 1,077 LIPID patients with diabetes and 940 patients with impaired fasting glucose (IFG)...
  3. ncbi request reprint Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
    R John Simes
    National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia
    Circulation 105:1162-9. 2002
    ..0 to 7.0 mmol/L at baseline. Secondary objectives included assessment of CHD event reduction according to lipid levels...
  4. doi request reprint Low-dose aspirin for preventing recurrent venous thromboembolism
    Timothy A Brighton
    Department of Haematology, South Eastern Area Laboratory Services SEALS, Prince of Wales Hospital, Sydney, Australia
    N Engl J Med 367:1979-87. 2012
    ..Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism...